v3.26.1
Certain transactions (Tables)
 12 Months Ended
Dec. 31, 2025
Summary of Major Classes of Assets and Liabilities Included as Held for Sale
The table below summarizes all of Teva’s assets and liabilities included as held for sale as of December 31, 2025 and December 31, 2024:
 
    
December 31,
     
December 31,
  
    
2025
     
2024
  
    
(U.S. $ in millions)
  
Accounts receivables
    $ 86        222  
Inventories
      506      $ 647  
Property, plant and equipment, net
      1,020        913  
Identifiable intangible assets, net
      29        83  
Goodwill
      213        255  
Other current assets
      87        99  
Other
non-current
assets
      184        236  
Expected loss on sale*
      (283 )       (684 ) 
  
 
 
     
 
 
  
Total assets of the disposal group classified as held for sale in the consolidated balance sheets
    $ 1,842      $ 1,771  
  
 
 
     
 
 
  
Accounts payables
      (261 )       (283 ) 
Other current liabilities
      (16 )       (49 ) 
Other
non-current
liabilities
      (77 )       (85 ) 
Expected loss on sale*
      —         (281 ) 
  
 
 
     
 
 
  
Total liabilities of the disposal group classified as held for sale in the consolidated balance sheets
    $ (354 )     $ (698 ) 
  
 
 
     
 
 
  
 
*
Includes an expected loss from reclassification of currency translation adjustments to the consolidated statements of income (loss) upon sale.